Ciliary Neurotrophic Factor Analogue Aggravates CCl4-induced Acute Hepatic Injury in Rats.

Ming-Xia Cui,Jun-Feng Jiang,Guang-Ning Min,Wei Han,Yong-Jie Wu
DOI: https://doi.org/10.1139/cjpp-2016-0564
2017-01-01
Canadian Journal of Physiology and Pharmacology
Abstract:Ciliary neurotrophic factor (CNTF) and CNTF analogs were reported to have hepatoprotective effect and ameliorate hepatic steatosis in db/db or high-fat-diet-fed mice. Because hepatic steatosis and injury are also commonly induced by hepatotoxin, the aim of the present study is to clarify whether CNTF could alleviate hepatic steatosis and injury induced by carbon tetrachloride (CCl4). Unexpectedly, when combined with CCl4, CNTF aggravated hepatic steatosis and liver injury. The mechanism is associated with effects of CNTF that inhibited lipoprotein secretion and drastically impaired the ability of lipoproteins to act as transport vehicles for lipids from the liver to the circulation. While injected after CCl4 cessation, CNTF could improve liver function. These data suggest that CNTF could be a potential hepatoprotective agent against CCl4-induced hepatic injury after the cessation of CCl4 exposure. However, it is forbidden to combine recombinant mutant of human CNTF treatment with CCl4.
What problem does this paper attempt to address?